» Articles » PMID: 25870284

Glycolytic Flux Controls D-serine Synthesis Through Glyceraldehyde-3-phosphate Dehydrogenase in Astrocytes

Overview
Specialty Science
Date 2015 Apr 15
PMID 25870284
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

D-Serine is an essential coagonist with glutamate for stimulation of N-methyl-D-aspartate (NMDA) glutamate receptors. Although astrocytic metabolic processes are known to regulate synaptic glutamate levels, mechanisms that control D-serine levels are not well defined. Here we show that d-serine production in astrocytes is modulated by the interaction between the D-serine synthetic enzyme serine racemase (SRR) and a glycolytic enzyme, glyceraldehyde 3-phosphate dehydrogenase (GAPDH). In primary cultured astrocytes, glycolysis activity was negatively correlated with D-serine level. We show that SRR interacts directly with GAPDH, and that activation of glycolysis augments this interaction. Biochemical assays using mutant forms of GAPDH with either reduced activity or reduced affinity to SRR revealed that GAPDH suppresses SRR activity by direct binding to GAPDH and through NADH, a product of GAPDH. NADH allosterically inhibits the activity of SRR by promoting the disassociation of ATP from SRR. Thus, astrocytic production of D-serine is modulated by glycolytic activity via interactions between GAPDH and SRR. We found that SRR is expressed in astrocytes in the subiculum of the human hippocampus, where neurons are known to be particularly vulnerable to loss of energy. Collectively, our findings suggest that astrocytic energy metabolism controls D-serine production, thereby influencing glutamatergic neurotransmission in the hippocampus.

Citing Articles

Glucose metabolism and endometrium decidualization.

Huang Y, Zhu Q, Sun Y Front Endocrinol (Lausanne). 2025; 16:1546335.

PMID: 40034230 PMC: 11872720. DOI: 10.3389/fendo.2025.1546335.


Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.

Trejo-Solis C, Silva-Adaya D, Serrano-Garcia N, Magana-Maldonado R, Jimenez-Farfan D, Ferreira-Guerrero E Int J Mol Sci. 2023; 24(24).

PMID: 38139462 PMC: 10744281. DOI: 10.3390/ijms242417633.


Aging and memory are altered by genetically manipulating lactate dehydrogenase in the neurons or glia of flies.

Frame A, Robinson J, Mahmoudzadeh N, Tennessen J, Simon A, Cumming R Aging (Albany NY). 2023; 15(4):947-981.

PMID: 36849157 PMC: 10008500. DOI: 10.18632/aging.204565.


Brain Energy Metabolism: Astrocytes in Neurodegenerative Diseases.

Chen Z, Yuan Z, Yang S, Zhu Y, Xue M, Zhang J CNS Neurosci Ther. 2022; 29(1):24-36.

PMID: 36193573 PMC: 9804080. DOI: 10.1111/cns.13982.


Selective Ablation of in Astrocytes Induces Sex-Specific Effects on Cognitive Function, d-Serine Availability, and Astrogliosis.

Baier M, Nagaraja R, Yarbrough H, Owen D, Masingale A, Ranjit R J Neurosci. 2022; 42(31):5992-6006.

PMID: 35760531 PMC: 9351643. DOI: 10.1523/JNEUROSCI.2543-21.2022.


References
1.
Wolosker H, Blackshaw S, Snyder S . Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci U S A. 1999; 96(23):13409-14. PMC: 23961. DOI: 10.1073/pnas.96.23.13409. View

2.
Rothman D, Behar K, Hyder F, Shulman R . In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol. 2003; 65:401-27. DOI: 10.1146/annurev.physiol.65.092101.142131. View

3.
Mothet J, Parent A, Wolosker H, Brady Jr R, Linden D, Ferris C . D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 2000; 97(9):4926-31. PMC: 18334. DOI: 10.1073/pnas.97.9.4926. View

4.
De Miranda J, Santoro A, Engelender S, Wolosker H . Human serine racemase: moleular cloning, genomic organization and functional analysis. Gene. 2000; 256(1-2):183-8. DOI: 10.1016/s0378-1119(00)00356-5. View

5.
Cholet N, Pellerin L, Welker E, LACOMBE P, Seylaz J, Magistretti P . Local injection of antisense oligonucleotides targeted to the glial glutamate transporter GLAST decreases the metabolic response to somatosensory activation. J Cereb Blood Flow Metab. 2001; 21(4):404-12. DOI: 10.1097/00004647-200104000-00009. View